Stocks News

LAST PRICE
80.8300
TODAY'S CHANGE (%)
Trending Down-7.0800 (-8.0537%)

Bid / Lots
71.5000/ 1
Ask / Lots
93.4500/ 18
Open / Previous Close
86.8200 / 87.9100
Day Range
Low 79.5000
High 87.0271
52 Week Range
Low 49.2400
High 94.5700
Volume
203,347
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- DJ Ligand Pharmaceuticals Down Nearly 9%, on Pace for Largest Percent Decrease Since January 2023 -- Data Talk, from 11 hours ago by Dow Jones
  11 hours ago by Dow Jones
  Companies Mentioned: LGND
  
  Ligand Pharmaceuticals Incorporated ( LGND ) is currently at $80.10, down $7.81 or 8.88%
  
  --Would be lowest close since May 7, 2024, when it closed at $73.22
May 23, 2024
- Ligand to Participate in Upcoming Investor Conferences, from 4:59PM ET on Thursday May 23, 2024 by Business Wire
  4:59PM ET on Thursday May 23, 2024 by Business Wire
  Companies Mentioned: LGND
  Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Todd Davis (Chief Executive Officer) and Tavo Espinoza (Chief Financial Officer) will participate in the following upcoming investor conferences:
- Ligand to Participate in Upcoming Investor Conferences, from 4:59PM ET on Thursday May 23, 2024 by Dow Jones
  4:59PM ET on Thursday May 23, 2024 by Dow Jones
  Companies Mentioned: LGND
  JUPITER, Fla.--(BUSINESS WIRE)--May 23, 2024--
  Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Todd Davis (Chief Executive Officer) and Tavo Espinoza (Chief Financial Officer) will participate in the following upcoming investor conferences:
May 13, 2024
- Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing, from 5:44PM ET on Monday May 13, 2024 by MT Newswires
  5:44PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: LGND
  05:44 PM EDT, 05/13/2024 (MT Newswires) -- Andrew Reardon, Chief Legal Officer, on May 09, 2024, sold 10,000 shares in Ligand Pharmaceuticals (LGND) for $830,449. Following the Form 4 filing with the SEC, Reardon has control over a total of 22,205 s...
May 8, 2024
- Sector Update: Health Care Stocks Softer Late Afternoon, from 3:59PM ET on Wednesday May 08, 2024 by MT Newswires
  3:59PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: LGND, MYGN, MASI
  03:59 PM EDT, 05/08/2024 (MT Newswires) -- Health care stocks were slipping late Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing around 0.3%. The iShares Biotechnology ETF (IBB) decr...

Jun 3, 2024
- --Lake Street Raises Price Target on Harrow to $25 From $20, Maintains Buy Rating, from 11:38AM ET on Monday Jun 03, 2024 by MT Newswires
  11:38AM ET on Monday Jun 03, 2024 by MT Newswires
  Companies Mentioned: HROW
May 30, 2024
- Avadel Pharmaceuticals to Present at Upcoming Investor Conferences, from 8:00AM ET on Thursday May 30, 2024 by GlobeNewswire
  8:00AM ET on Thursday May 30, 2024 by GlobeNewswire
  Companies Mentioned: AVDL
May 29, 2024
- Tarsus to Participate in Upcoming Investor Conferences, from 5:00PM ET on Wednesday May 29, 2024 by GlobeNewswire
  5:00PM ET on Wednesday May 29, 2024 by GlobeNewswire
  Companies Mentioned: TARS
May 22, 2024
- Avadel Pharmaceuticals Shares New LUMRYZ(TM) (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024, from 8:00AM ET on Wednesday May 22, 2024 by GlobeNewswire
  8:00AM ET on Wednesday May 22, 2024 by GlobeNewswire
  Companies Mentioned: AVDL
May 21, 2024
- Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors, from 7:00AM ET on Tuesday May 21, 2024 by GlobeNewswire
  7:00AM ET on Tuesday May 21, 2024 by GlobeNewswire
  Companies Mentioned: AVDL
May 15, 2024
- --B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating, from 8:00AM ET on Wednesday May 15, 2024 by MT Newswires
  8:00AM ET on Wednesday May 15, 2024 by MT Newswires
  Companies Mentioned: HROW
- Harrow to Present at Two Investor Conferences in May, from 7:00AM ET on Wednesday May 15, 2024 by Business Wire
  7:00AM ET on Wednesday May 15, 2024 by Business Wire
  Companies Mentioned: HROW
May 14, 2024
- European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading, from 11:07AM ET on Tuesday May 14, 2024 by MT Newswires
  11:07AM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: ERIC, AVDL, NOK, SNN, SNY, TRIB, VOD, SQNS, AUTL, GNFT, CALT, BHP, SHEL, DBVT, BDRX, EDAP
May 13, 2024
- Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours, from 4:25PM ET on Monday May 13, 2024 by MT Newswires
  4:25PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: HROW
- Harrow Announces First Quarter 2024 Financial Results, from 4:01PM ET on Monday May 13, 2024 by Business Wire
  4:01PM ET on Monday May 13, 2024 by Business Wire
  Companies Mentioned: HROW

Ligand Pharmaceuticals Inc
NASDAQ:LGNDUnited States

Search Criteria

Yesterday

DJ Ligand Pharmaceuticals Down Nearly 9%, on Pace for Largest Percent Decrease Since January 2023 -- Data Talk, from 11 hours ago by Dow Jones

May 23, 2024

Ligand to Participate in Upcoming Investor Conferences, from 4:59PM ET on Thursday May 23, 2024 by Business Wire

Ligand to Participate in Upcoming Investor Conferences, from 4:59PM ET on Thursday May 23, 2024 by Dow Jones

May 13, 2024

Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing, from 5:44PM ET on Monday May 13, 2024 by MT Newswires

May 8, 2024

Sector Update: Health Care Stocks Softer Late Afternoon, from 3:59PM ET on Wednesday May 08, 2024 by MT Newswires

Peers Headlines

Jun 3, 2024

--Lake Street Raises Price Target on Harrow to $25 From $20, Maintains Buy Rating, from 11:38AM ET on Monday Jun 03, 2024 by MT Newswires

May 30, 2024

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences, from 8:00AM ET on Thursday May 30, 2024 by GlobeNewswire

May 29, 2024

Tarsus to Participate in Upcoming Investor Conferences, from 5:00PM ET on Wednesday May 29, 2024 by GlobeNewswire

May 22, 2024

Avadel Pharmaceuticals Shares New LUMRYZ(TM) (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024, from 8:00AM ET on Wednesday May 22, 2024 by GlobeNewswire

May 21, 2024

Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors, from 7:00AM ET on Tuesday May 21, 2024 by GlobeNewswire

May 15, 2024

--B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating, from 8:00AM ET on Wednesday May 15, 2024 by MT Newswires

Harrow to Present at Two Investor Conferences in May, from 7:00AM ET on Wednesday May 15, 2024 by Business Wire

May 14, 2024

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading, from 11:07AM ET on Tuesday May 14, 2024 by MT Newswires

May 13, 2024

Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours, from 4:25PM ET on Monday May 13, 2024 by MT Newswires

Harrow Announces First Quarter 2024 Financial Results, from 4:01PM ET on Monday May 13, 2024 by Business Wire